Q517--Contingency Compounded Sterile Products Service

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 16 in Ridgeland, Mississippi is conducting market research for 503A pharmaceutical compounding services to support the G.V. Sonny Montgomery VA Medical Center in Jackson, Mississippi. The agency seeks contractors capable of compounding hazardous chemotherapy agents for approximately 10-12 patients daily at an FDA 503A compliant facility, with delivery required by 11:30 AM CST the day after order submission. Contractors must maintain compliance with USP 797, USP 800, and federal regulations, provide documentation of FDA 503A compliance and pharmacy licenses, and have contingency backup plans in place. Interested businesses must submit their business name, point of contact, SAM UEI, and a two-page capability statement to tammie.chaney@va.gov by 10:00 AM CT on Tuesday, August 26, 2025. This sources sought notice operates under NAICS code 325412 with a small business size standard of 1,300 employees, and responses will be used solely for market research purposes with no guarantee of future solicitation.

This opportunity does not include any set-aside designations and no incumbent contractors are identified in the documentation. The proposed contract structure will be a firm-fixed price, Indefinite-Delivery-Indefinite Quantity (IDIQ) arrangement spanning five one-year ordering periods from October 1, 2025, through September 30, 2030. The contractor will be responsible for aseptically compounding patient-specific chemotherapy agents for approximately 10-12 patients on a daily basis, utilizing specific IV equipment and closed system drug-transfer devices as required by the medical center. No specific contract values or budget ranges are disclosed in this preliminary market research phase, and the VA emphasizes this is purely an information-gathering exercise that may or may not result in a formal solicitation.